[go: up one dir, main page]

MX2010008065A - Metodo de selección de antioxidantes para su uso en composiciones de aplicación topica. - Google Patents

Metodo de selección de antioxidantes para su uso en composiciones de aplicación topica.

Info

Publication number
MX2010008065A
MX2010008065A MX2010008065A MX2010008065A MX2010008065A MX 2010008065 A MX2010008065 A MX 2010008065A MX 2010008065 A MX2010008065 A MX 2010008065A MX 2010008065 A MX2010008065 A MX 2010008065A MX 2010008065 A MX2010008065 A MX 2010008065A
Authority
MX
Mexico
Prior art keywords
skin
methods
topically applied
applied compositions
compositions
Prior art date
Application number
MX2010008065A
Other languages
English (en)
Inventor
Thomas A Meyer
Donathan G Beasley
Original Assignee
Schering Plough Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Healthcare filed Critical Schering Plough Healthcare
Publication of MX2010008065A publication Critical patent/MX2010008065A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)

Abstract

Composiciones que tienen antioxidantes y métodos para confirmar la actividad antioxidante de una composición formulada para aplicación tópica a la piel; métodos para probar una composición para su capacidad de inhibir tanto la peroxidación de lípidos inducida por radiación ultravioleta en la piel como la formación de especies reactivas de oxígeno inducidas por radiación ultravioleta en el estrato córneo; composiciones y métodos para tratar y prevenir fotodaño a la piel.
MX2010008065A 2008-01-25 2009-01-21 Metodo de selección de antioxidantes para su uso en composiciones de aplicación topica. MX2010008065A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2371308P 2008-01-25 2008-01-25
US11475808P 2008-11-14 2008-11-14
PCT/US2009/031538 WO2009094374A2 (en) 2008-01-25 2009-01-21 Method of selecting antioxidants for use in topically applied compositions

Publications (1)

Publication Number Publication Date
MX2010008065A true MX2010008065A (es) 2010-10-20

Family

ID=40427148

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008065A MX2010008065A (es) 2008-01-25 2009-01-21 Metodo de selección de antioxidantes para su uso en composiciones de aplicación topica.

Country Status (13)

Country Link
US (4) US20090189090A1 (es)
EP (1) EP2247949B1 (es)
JP (2) JP2011511770A (es)
CN (2) CN103394088B (es)
AR (1) AR072444A1 (es)
AU (1) AU2009206489B2 (es)
BR (1) BRPI0908478A2 (es)
CA (1) CA2711270C (es)
ES (1) ES2637516T3 (es)
HR (1) HRP20171215T1 (es)
MX (1) MX2010008065A (es)
PT (1) PT2247949T (es)
WO (1) WO2009094374A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090189090A1 (en) * 2008-01-25 2009-07-30 Schering-Plough Healthcare Products, Inc. Method of selecting antioxidants for use in topically applied compositions
US9116112B2 (en) * 2011-07-11 2015-08-25 Jr Chem Llc UV protective skin treatment compositions and screening methods
US9005584B2 (en) 2012-06-08 2015-04-14 S.C. Johnson & Son, Inc. Spray formulations with reduced clogging/sedimentation characteristics
MX2015003901A (es) * 2012-09-27 2015-10-22 Msd Consumer Care Inc Formulaciones espumantes de cuidado de la piel.
EP2934430B1 (en) * 2012-12-19 2019-11-06 L'Oréal Sunscreen compositions having synergistic combination of uv filters
US9132074B2 (en) 2012-12-19 2015-09-15 L'oreal Sunscreen compositions having synergistic combination of UV filters
JP6072545B2 (ja) * 2013-01-18 2017-02-01 株式会社ミルボン 非水系毛髪化粧料
RU2524643C1 (ru) * 2013-08-06 2014-07-27 Общество с ограниченной ответственностью Научно-Технический Центр "Химинвест" Способ приготовления противовоспалительной ветеринарной мази
US20170112947A1 (en) * 2014-06-05 2017-04-27 The Trustees Of Columbia University In The City Of New York Composition for use in imaging
WO2016176485A1 (en) 2015-04-29 2016-11-03 Petkoska Anka T Antioxidant compositions and methods of protecting skin, hair and nails against high energy blue-violet light
US9889080B2 (en) 2015-05-07 2018-02-13 Celeb LLC Color depositing shampoo
US10245221B2 (en) 2015-05-07 2019-04-02 Celeb LLC Stabilized color depositing shampoo
US9539195B1 (en) 2015-06-25 2017-01-10 L'oreal Sunscreen compositions having synergistic combination of UV filters
US9539194B1 (en) 2015-06-25 2017-01-10 L'oreal Sunscreen compositions having synergistic combination of UV filters
US9572759B2 (en) 2015-06-25 2017-02-21 L'oreal Sunscreen compositions having synergistic combination of UV filters
CN105085223B (zh) * 2015-07-31 2017-06-23 安徽圣诺贝化学科技有限公司 一种制备阿伏苯宗的方法
US10485745B2 (en) * 2016-04-29 2019-11-26 L'oreal UV-A/UV-B sunscreen composition
US11390808B2 (en) 2017-06-30 2022-07-19 Shiseido Company, Ltd. Singlet oxygen scavenger
CN107362129B (zh) * 2017-08-23 2019-10-18 广东丸美生物技术股份有限公司 护肤基质、制备方法及其应用和化妆品及其制备方法
CN108553403B (zh) * 2018-04-20 2019-09-27 上海中翊日化有限公司 一种嗜热栖热菌和酵母菌组合发酵产物的用途
KR102631708B1 (ko) 2018-06-19 2024-01-31 삼성전자주식회사 항산화 지수 측정 장치 및 방법
CN109520947B (zh) * 2018-11-26 2020-12-22 齐鲁工业大学 一种发酵液中3-羟基丁酮定量测定的方法
CN109350577B (zh) * 2018-12-13 2021-09-21 广州睿森生物科技有限公司 一种护肤组合物及其应用
US11110257B2 (en) * 2018-12-27 2021-09-07 Johnson & Johnson Consumer Inc. Device and method for selective application of topical composition using dynamic threshold values
US20220062126A1 (en) * 2019-01-04 2022-03-03 Beiersdorf Ag Uv screening and antioxidant composition and use thereof
JP2020125254A (ja) * 2019-02-04 2020-08-20 株式会社協和 化粧料、紫外線に対する細胞保護剤、光老化防止剤
US11583480B2 (en) * 2019-08-27 2023-02-21 L'oreal Sunscreen composition with a high UV filter load
CN110897938A (zh) * 2019-12-23 2020-03-24 广州倍健医疗用品有限公司 一种速泡抑菌抗皱洁面泡泡及其制备方法
AU2021321595A1 (en) 2020-08-03 2023-04-06 Kenvue Brands Llc System and method for selective application of cosmetic composition to impart undereye brightening
CN114674734A (zh) * 2022-04-20 2022-06-28 无限极（中国）有限公司 一种评价化妆品产品及原料抗氧化功效的方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975272A (en) * 1976-11-10 1990-12-04 Voyt Walter F Method of and composition for the prevention of solar radiation exposure-induced formation of carcinogenic skin lipid degradation products
CN1086532A (zh) * 1992-11-05 1994-05-11 上海南源永芳发展有限公司 一种用于美容护肤制剂的抗氧化剂
DE4242949A1 (de) * 1992-12-18 1994-06-23 Bayer Ag Feinteiliges, hochreines, neutrales Zinkoxidpulver, Verfahren zu dessen Herstellung und seine Verwendung
TW448161B (en) * 1994-07-14 2001-08-01 Otsuka Pharma Co Ltd Cyclic amide derivatives
US5817299A (en) * 1996-11-01 1998-10-06 E-L Management Corp. Non-chemical sunscreen composition
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US6015548A (en) * 1998-07-10 2000-01-18 Shaklee Corporation High efficiency skin protection formulation with sunscreen agents and antioxidants
AU1944599A (en) 1997-12-24 1999-07-19 Shaklee Corporation Composition with high efficiency skin protection from damaging effects of ultraviolet light
JPH11287795A (ja) * 1998-04-03 1999-10-19 Pola Chem Ind Inc メークアップ化粧料の評価法
EP1230926A4 (en) * 1999-10-14 2006-03-15 Nisshin Oillio Ltd SKIN CARE, AGING PROTECTION AND SKIN BLEACHING AGENTS AND EXTERNAL SKIN PREPARATIONS
AU1784301A (en) * 1999-11-24 2001-06-04 Alticor Inc. Topical skin composition
US6254898B1 (en) * 2000-05-25 2001-07-03 Protective Factors, Inc. Nutraceutical composition for protection against solar radiation
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
JP4463549B2 (ja) * 2001-07-16 2010-05-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸化防止特性を有する光安定性の有機日焼け止め化合物およびそれから得られる組成物
EP1344516A1 (de) 2002-03-12 2003-09-17 Cognis Iberia, S.L. Antioxidative Zubereitungen
US20040253332A1 (en) * 2002-04-11 2004-12-16 Chaudhuri Ratan K. Method for regulating the appearance of skin containing combination of skin care actives
US20060177888A1 (en) * 2003-03-20 2006-08-10 Chugai Seiyaku Kabushiki Kaisha Method for evaluating antioxidation capability of organism sample
WO2004095022A1 (ja) * 2003-04-21 2004-11-04 Shiseido Company, Ltd. 角層における酸化タンパク質の評価方法
US7166273B2 (en) * 2003-06-03 2007-01-23 Emd Chemicals, Inc. Photo stable organic sunscreen compositions
US20050031655A1 (en) * 2003-08-04 2005-02-10 Schering Plough Healthcare Products, Inc. Emulsion composition
DE102004010313A1 (de) * 2004-03-03 2005-09-22 Merck Patent Gmbh UV-Filter in Puderform
DK2233127T3 (da) * 2004-03-17 2020-08-24 Stada Arzneimittel Ag Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
EP1591099A3 (en) * 2004-04-28 2005-11-09 MERCK PATENT GmbH Methods for stabilizing ingredients within cosmetics, personal care and household products
WO2006086707A2 (en) * 2005-02-11 2006-08-17 Kalamazoo Holdings, Inc. Extracts of asteraceae containing reduced levels of phototoxic thiophene derivatives and methods for preparing same
CN101203278A (zh) * 2005-04-19 2008-06-18 默克专利股份有限公司 紫外线保护
US20060263321A1 (en) * 2005-05-17 2006-11-23 The Procter & Gamble Company Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate
US20060263309A1 (en) * 2005-05-17 2006-11-23 Bissett Donald L Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin
US20070020203A1 (en) * 2005-07-07 2007-01-25 Chaudhuri Ratan K Skin care composition
CN101394831B (zh) * 2005-12-15 2012-11-14 卢塞迪奥·格莱西 氮氧化物抗氧化剂的合成和在化妆用和皮肤病用组合物中的使用方法
CN101384239A (zh) * 2005-12-21 2009-03-11 先灵-普劳健康护理产品公司 Uv辐射保护剂组合物
MX2009000147A (es) * 2006-06-27 2009-06-11 Schering Plough Healthcare Formulaciones de locion en aerosol.
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
DE102007005186A1 (de) * 2007-01-29 2008-07-31 Merck Patent Gmbh Partikuläres UV-Schutzmittel
US20080305059A1 (en) * 2007-06-06 2008-12-11 Chaudhuri Ratan K Skin lightening compositions and methods
US20090189090A1 (en) * 2008-01-25 2009-07-30 Schering-Plough Healthcare Products, Inc. Method of selecting antioxidants for use in topically applied compositions

Also Published As

Publication number Publication date
CN103394088A (zh) 2013-11-20
US9096882B2 (en) 2015-08-04
CN103394088B (zh) 2017-01-18
CA2711270A1 (en) 2009-07-30
ES2637516T3 (es) 2017-10-13
US20130101515A1 (en) 2013-04-25
JP6154426B2 (ja) 2017-06-28
BRPI0908478A2 (pt) 2015-08-18
EP2247949B1 (en) 2017-05-24
JP2011511770A (ja) 2011-04-14
CN101925816A (zh) 2010-12-22
AU2009206489B2 (en) 2014-10-02
US20160033538A1 (en) 2016-02-04
AR072444A1 (es) 2010-09-01
US20190285657A1 (en) 2019-09-19
CA2711270C (en) 2017-02-28
HRP20171215T1 (hr) 2017-12-15
AU2009206489A1 (en) 2009-07-30
WO2009094374A3 (en) 2009-09-17
EP2247949A2 (en) 2010-11-10
PT2247949T (pt) 2017-08-25
WO2009094374A2 (en) 2009-07-30
JP2015163624A (ja) 2015-09-10
US20090189090A1 (en) 2009-07-30
US10241121B2 (en) 2019-03-26

Similar Documents

Publication Publication Date Title
MX2010008065A (es) Metodo de selección de antioxidantes para su uso en composiciones de aplicación topica.
BRPI0910874A8 (pt) composições e métodos para cuidado da pele
WO2010002586A3 (en) Topical compositions comprising isonicotinamide
CL2007002095A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado.
MY175521A (en) Melanin modification compositions and methods of use
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
CL2011000186A1 (es) Metodos para eliminar o prevenir el crecimiento de un microbio en un sustrato mediante la aplicacion de compuestos derivados de tetrakis (n-alquilpiridinio)- porfirina; composicion topica que comprende dicho compuesto; y metodo para prevenir y tratar una infeccion de la piel en un sujeto.
WO2009105294A3 (en) Topical compositions and methods for whitening skin
WO2012068357A3 (en) Cosmetic compositions and methods for inhibiting or reducing trypsin activity based on cyclohexane- 1, 2, 3, 4, 5, 6 -hexol and a n-acyl amino acid compound
WO2010013110A3 (en) Composition comprising estrone and hydrocortisone for use in the topical treatment of baldness
MY158428A (en) Topical composition for the treatment of actinic keratosis
CL2007002228A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado.
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
WO2009158248A3 (en) Method and compositions for improving skin and body appearance
WO2010072787A3 (en) A composition comprising a retinoid and method of treating skin conditions
WO2010017609A3 (en) Antiperspirant compositions and methods for reducing perspiration in humans
MX2016003091A (es) Composicion que comprende extracto de guacatonga y extracto de aroeira, uso de la misma para prevenir y/o tratar el envejecimiento de la piel.
AU2008321142A8 (en) Heterocyclic derivatives as modulators of ion channels
NZ571858A (en) Methods of treating, reducing and inhibiting the appearance of ageing in the skin
WO2006083979A3 (en) Local treatment of neurofibromas
MXPA05013665A (es) Composiciones cosmeticas autobronceantes que comprenden un compuesto de vitamina b3 soluble en agua y un agente alfa-hidroxicarbonilo autobronceante.
WO2010065194A3 (en) Compositions and methods for promoting a relaxation state
WO2011001111A3 (fr) Utilisation d'un composé d'acide jasmonique pour traiter la peau grasse
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
WO2009071855A3 (fr) Composition cosmetique ou dermatologique contenant un extrait d'orchidee et methode de soin cosmetique utilisant cette composition.

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: ALDERBIO HOLDINGS LLC

FG Grant or registration
PD Change of proprietorship

Owner name: SCHERING-PLOUGH CORPORATION, U.S.A.